ISA101b
ISA101b-HN-01-17
Phase 2 mab active
Quick answer
ISA101b for Squamous Cell Carcinoma of the Oropharynx is a Phase 2 program (mab) at REGENERON PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Squamous Cell Carcinoma of the Oropharynx
- Phase
- Phase 2
- Modality
- mab
- Status
- active